The recent discovery that highly pathogenic Gram-positive bacteria express antigens recognized by both mouse and human iNKT cells [8] therefore opens important perspectives for the development of therapeutic agents against pneumonia and meningitis, while also suggesting a potential rationale for the conserved features of the CD1d-TCR interaction among different mammalian species. This evidence concerns the gene CD1D and susceptibility to pneumonia measurement.